CareDx Inc
For the period ended Dec 31, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
CDNA$80.77-4.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
(In thousands, except share amounts)
| Common Stock · Additional Paid-In Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’ Equity | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | |||||
| Balance at December 31, 2021 | 52,923,360 | $52 | $853,683 | $(4,670) | $(383,189) | $465,876 |
| Issuance of common stock under employee stock purchase plan | 93,422 | — | 2,230 | — | — | 2,230 |
| Repurchase and retirement of common stock | (50,051) | — | — | — | (642) | (642) |
| RSU settlements, net of shares withheld | 411,176 | — | (6,067) | — | — | (6,067) |
| Issuance of common stock for services | 12,764 | — | 319 | — | — | 319 |
| Issuance of common stock for cash upon exercise of stock options | 142,579 | — | 2,435 | — | — | 2,435 |
| Employee stock-based compensation expense | — | — | 46,206 | — | — | 46,206 |
| Foreign currency translation adjustment | — | — | — | (2,833) | — | (2,833) |
| Net loss | — | — | — | — | (76,613) | (76,613) |
| Balance at December 31, 2022 | 53,533,250 | 52 | 898,806 | (7,503) | (460,444) | 430,911 |
| Issuance of common stock under employee stock purchase plan | 190,841 | — | 1,495 | — | — | 1,495 |
| Repurchase and retirement of common stock | (2,942,997) | (3) | — | — | (27,541) | (27,544) |
| RSU settlements, net of shares withheld | 669,283 | — | (3,059) | — | — | (3,059) |
| Issuance of common stock for services | 21,965 | — | 216 | — | — | 216 |
| Issuance of common stock for cash upon exercise of stock options | 27,903 | — | 120 | — | — | 120 |
| Issuance of common stock for cash upon exercise of warrants | 3,132 | — | 26 | — | — | 26 |
| Employee stock-based compensation expense | — | — | 48,907 | — | — | 48,907 |
| Foreign currency translation adjustment | — | — | — | 540 | — | 540 |
| Net loss | — | — | — | — | (190,284) | (190,284) |
| Balance at December 31, 2023 | 51,503,377 | 49 | 946,511 | (6,963) | (678,269) | 261,328 |
| Issuance of common stock under employee stock purchase plan | 159,019 | — | 1,397 | — | — | 1,397 |
| Repurchase and retirement of common stock | (55,500) | — | — | — | (522) | (522) |
| RSU settlements, net of shares withheld | 2,620,716 | 2 | (10,092) | — | — | (10,090) |
| Issuance of common stock for services | 16,582 | — | 174 | — | — | 174 |
| Issuance of common stock for cash upon exercise of stock options | 527,009 | — | 8,936 | — | — | 8,936 |
| Employee stock-based compensation expense | — | — | 66,267 | — | — | 66,267 |
| Foreign currency translation adjustment | — | — | — | (1,606) | — | (1,606) |
| Net income | — | — | — | — | 52,549 | 52,549 |
| Balance at December 31, 2024 | 54,771,203 | $51 | $1,013,193 | $(8,569) | $(626,242) | $378,433 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.